JPMorgan lowered the firm’s price target on GSK (GSK) to 1,440 GBp from 1,550 GBp and keeps an Underweight rating on the shares.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.